RESUMEN
BACKGROUND: The American Geriatrics Society (AGS) Beers Criteria is an explicit list of potentially inappropriate medications (PIMs) best avoided in adults ≥65 years of age. Cognitively impaired and frail surgical patients often experience poor outcomes after surgery, but the impacts of PIMs on these patients are unclear. Our objective was to assess whether perioperative PIM administration was associated with poor outcomes in geriatric surgical patients. We then evaluated the association between PIM administration and postoperative outcomes in subgroups of patients who were frail or cognitively impaired. METHODS: We performed a retrospective cohort study of patients ≥65 years of age who underwent elective inpatient surgery at a large academic medical center from February 2018 to January 2020. Edmonton Frail Scale and Mini-Cog screening tools were administered to all patients at their preoperative clinic visit. A Mini-Cog score of 0 to 2 was considered cognitive impairment, and frailty was defined by an Edmonton Frail Scale score of ≥8. Patients were divided into 2 groups depending on whether they received at least 1 PIM (PIM+), based on the 2019 AGS Beers Criteria, in the perioperative period or none (PIM-). We assessed the association of preoperative frailty, cognitive impairment, and perioperative PIM administration with the length of hospital stay and discharge disposition using multiple regression analyses adjusted for age, sex, ASA physical status, and intensive care unit (ICU) admission. RESULTS: Of the 1627 included patients (mean age, 73.7 years), 69.3% (n = 1128) received at least 1 PIM. A total of 12.7% of patients were frail, and 11.1% of patients were cognitively impaired; 64% of the frail patients and 58% of the cognitively impaired patients received at least 1 PIM. Perioperative PIM administration was associated with longer hospital stay after surgery (PIM-, 3.56 ± 5.2 vs PIM+, 4.93 ± 5.66 days; P < .001; 95% confidence interval [CI], 0.360-0.546). Frail patients who received PIMs had an average length of stay (LOS) that was nearly 2 days longer than frail patients who did not receive PIMs (PIM-, 4.48 ± 5.04 vs PIM+, 6.33 ± 5.89 days; P = .02). Multiple regression analysis revealed no significant association between PIM administration and proportion of patients discharged to a care facility (PIM+, 26.3% vs PIM-, 28.7%; P = .87; 95% CI, -0.046 to 0.054). CONCLUSIONS: Perioperative PIM administration was common in older surgical patients, including cognitively impaired and frail patients. PIM administration was associated with an increased hospital LOS, particularly in frail patients. There was no association found between PIM administration and discharge disposition.
Asunto(s)
Fragilidad , Lista de Medicamentos Potencialmente Inapropiados , Humanos , Anciano , Estudios Retrospectivos , Alta del Paciente , HospitalizaciónRESUMEN
BACKGROUND: The COVID-19 pandemic resulted in the need for hospitals to plan for a potential "surge" of COVID-19 patients. PROBLEM: Prior to the onset of the COVID-19 pandemic, our hospital adult acute care capacity ranged 90% to 100%, and a potential hospital surge was projected for Oregon that would exceed existing capacity. APPROACH: A multidisciplinary team with stakeholders from nursing leadership, nursing units, nurse-led case management, and physicians from hospital medicine was convened to explore the conversion of an ambulatory surgical center to overflow patient acute care capacity. OUTCOMES: A protocol was rapidly created and implemented, ultimately transferring 12 patients to an ambulatory surgery unit. CONCLUSIONS: This project highlighted the ability for stakeholders and innovators to work together in an interprofessional, multidisciplinary way to rapidly create an overflow unit. While this innovation was designed to address COVID-19, the lessons learned can be applied to any other emerging infectious disease or acute care capacity crisis.
Asunto(s)
COVID-19/epidemiología , COVID-19/terapia , Planificación Hospitalaria/organización & administración , Innovación Organizacional , Grupo de Atención al Paciente/organización & administración , Humanos , Oregon/epidemiologíaAsunto(s)
Infecciones por Coronavirus , Pandemias , Neumonía Viral , Humanos , Betacoronavirus , COVID-19 , SARS-CoV-2 , SexismoRESUMEN
Frequently, the question of whether or not a patient is stable for surgery boils down to the question, "Does this patient need a preoperative stress test?" However, coronary artery disease and ischemic heart disease are only some of the many cardiac conditions that patients present with preoperatively-and that can negatively impact their intraoperative management and postoperative outcomes. This article will explore the evidence based, patient centered best practices surrounding the perioperative evaluation and management of heart failure, arrhythmias, and valvular heart disease.
Asunto(s)
Arritmias Cardíacas , Insuficiencia Cardíaca , Enfermedades de las Válvulas Cardíacas , Atención Perioperativa , Humanos , Enfermedades de las Válvulas Cardíacas/cirugía , Enfermedades de las Válvulas Cardíacas/complicaciones , Enfermedades de las Válvulas Cardíacas/terapia , Atención Perioperativa/métodos , Atención Perioperativa/normas , Arritmias Cardíacas/terapia , Arritmias Cardíacas/diagnóstico , Insuficiencia Cardíaca/terapiaRESUMEN
The COVID-19 pandemic has dramatically affected societies and healthcare systems around the globe. The perioperative care continuum has also been under significant strain due to the pandemic-tasked with simultaneously addressing surgical strains and backlogs, infection prevention strategies, and emerging data regarding significantly higher perioperative risk for COVID-19 patients and survivors. Many uncertainties persist regarding the perioperative risk, assessment, and management of COVID-19 survivors-and the energy to catch up on surgical backlogs must be tempered with strategies to continue to mitigate COVID-19 related perioperative risk. Here, we review the available data for COVID-19-related perioperative risk, discuss areas of persistent uncertainty, and empower the perioperative teams to pursue evidence-based strategies for high quality, patient-centered, team-based care as we enter the third year of the COVID-19 pandemic.
RESUMEN
Neurologic diseases are prevalent in patients undergoing invasive procedures; yet, no societal guidelines exist as to best practice in management of perioperative medications prescribed to treat these disorders. The Society for Perioperative Assessment and Quality Improvement tasked experts in internal medicine, anesthesiology, perioperative medicine, and neurology to provide evidence-based recommendations for preoperative management of these medications. The aim of this review is not only to provide consensus recommendations for preoperative management of patients on medications for neurologic disorders, but also to serve as an educational guide to perioperative clinicians. While, in general, medications for neurologic disorders should be continued preoperatively, an individualized approach may be needed in certain situations (eg, holding anticonvulsants on day of surgery if electroencephalographic mapping is planned during epilepsy surgery). Pertinent interactions with commonly used drugs in anesthesia practice, as well as considerations for targeted laboratory testing or perioperative drug substitutions, are addressed as well.
Asunto(s)
Consenso , Enfermedades del Sistema Nervioso/terapia , Atención Perioperativa/normas , Guías de Práctica Clínica como Asunto , Mejoramiento de la Calidad/normas , Sociedades Médicas/estadística & datos numéricos , Cardiología/normas , Humanos , Complicaciones Posoperatorias/prevención & control , Cuidados Preoperatorios/métodosRESUMEN
There is a lack of guidelines for preoperative management of psychiatric medications leading to variation in care and the potential for perioperative complications and surgical procedure cancellations on the day of surgery. The Society for Perioperative Assessment and Quality Improvement identified preoperative psychiatric medication management as an area in which consensus could improve patient care. The aim of this consensus statement is to provide recommendations to clinicians regarding preoperative psychiatric medication management. Several categories of drugs were identified including antidepressants, mood stabilizers, anxiolytics, antipsychotics, and attention deficit hyperactivity disorder medications. Literature searches and review of primary and secondary data sources were performed for each medication/medication class. We used a modified Delphi process to develop consensus recommendations for preoperative management of individual medications in each of these drug categories. While most medications should be continued perioperatively to avoid risk of relapse of the psychiatric condition, adjustments may need to be made on a case-by-case basis for certain drugs.
Asunto(s)
Trastornos Mentales/tratamiento farmacológico , Atención Perioperativa/normas , Guías de Práctica Clínica como Asunto , Mejoramiento de la Calidad/normas , Sociedades Médicas/estadística & datos numéricos , Cardiología/normas , Consenso , Humanos , Complicaciones Posoperatorias/prevención & control , Cuidados Preoperatorios/métodosAsunto(s)
Enfermedades del Sistema Nervioso Autónomo/etiología , Rubor/etiología , Ganglioneuroblastoma/complicaciones , Síndrome de Horner/etiología , Hipohidrosis/etiología , Enfermedades del Iris/etiología , Neoplasias del Mediastino/complicaciones , Trastornos de la Pigmentación/etiología , Adulto , Enfermedades del Sistema Nervioso Autónomo/diagnóstico , Diagnóstico Diferencial , Femenino , Rubor/diagnóstico , Ganglioneuroblastoma/diagnóstico , Síndrome de Horner/diagnóstico , Humanos , Hipohidrosis/diagnóstico , Enfermedades del Iris/diagnóstico , Neoplasias del Mediastino/diagnóstico , Trastornos de la Pigmentación/diagnósticoRESUMEN
The preoperative evaluation and risk assessment has always been a critical aspect of safe surgical practice, and in the midst of the SARS-CoV-2 pandemic, it has become even more crucial to patient safety. Emerging data show that surgical procedures in patients who test positive for coronavirus disease (COVID) are associated with worse clinical outcomes and increased postoperative complications and mortality. In addition to personal protective equipment (PPE) management, isolation protocols, preoperative SARS-CoV-2 screening, and steps to ensure clinician safety, determining how to deem patients who have recovered from COVID-19 safe to proceed is an added challenge. We present a preoperative protocol for evaluation of previously COVID-positive patients for elective surgery.
RESUMEN
There is a lack of guidelines for preoperative dosing of opioid and nonopioid pain medications for surgical patients, which can lead to suboptimal preoperative pain control. The Society for Perioperative Assessment and Quality Improvement identified preoperative dosing of opioid and nonopioid analgesics as an area in which consensus could improve patient care. The aim of this guideline is to provide consensus that will allow perioperative physicians to make optimal recommendations regarding preoperative pain medication dosing. Six categories of pain medications were identified: opioid agonists, opioid antagonists, opioid agonist-antagonists, acetaminophen, muscle relaxants, and triptans/headache medications. We then used a Delphi survey technique to develop consensus recommendations for preoperative dosing of individual medications in each of these groups.
Asunto(s)
Analgésicos no Narcóticos/administración & dosificación , Analgésicos Opioides/administración & dosificación , Dolor Postoperatorio/prevención & control , Cuidados Preoperatorios/normas , Analgésicos no Narcóticos/uso terapéutico , Analgésicos Opioides/uso terapéutico , Técnica Delphi , Relación Dosis-Respuesta a Droga , Esquema de Medicación , Cálculo de Dosificación de Drogas , Humanos , Cuidados Preoperatorios/métodos , Mejoramiento de la CalidadAsunto(s)
Hemólisis , Hiperbilirrubinemia/líquido cefalorraquídeo , Hemorragia Subaracnoidea/líquido cefalorraquídeo , Amoxicilina/efectos adversos , Antibacterianos/efectos adversos , Enfermedad Hepática Inducida por Sustancias y Drogas/líquido cefalorraquídeo , Enfermedad Hepática Inducida por Sustancias y Drogas/etiología , Humanos , Masculino , Persona de Mediana Edad , Oxihemoglobinas/líquido cefalorraquídeo , Punción EspinalRESUMEN
BACKGROUND: Iron overload is associated with fatal cardiovascular events following liver transplantation. Myocardial iron deposits were observed post-mortem in patients who died of cardiac events after transplantation at our institution. This observation prompted testing to exclude cardiac iron in subsequent transplant candidates. AIMS: To assess the results of testing for iron overload in liver transplant candidates at our institution. METHODS: Ferritin, TIBC, and serum iron were measured in cirrhotics referred for transplantation. Patients with transferrin saturation ≥50% and ferritin ≥250 ng/mL underwent liver biopsy graded for iron. Patients with 3-4+ hepatic iron deposits underwent HFE mutation analysis and endomyocardial biopsy with iron staining. RESULTS: Eight hundred and fifty-six patients were evaluated for liver transplantation between January 1997 and March 2005. Two hundred and eighty-seven patients (34%) had transferrin saturation ≥50% and ferritin ≥250 ng/mL. Patients with markers of iron overload had more advanced liver disease than those with normal iron indices. One hundred and fifty-three patients underwent liver biopsy. Twenty-six patients (17%) had 3-4+ hepatic iron staining. One patient was a C282Y heterozygote. Endomyocardial biopsy was performed in 14 patients of whom nine had cardiac iron deposition. CONCLUSIONS: Non-HFE-related cardiac iron overload can occur in advanced liver disease We therefore recommend screening for cardiac iron prior to liver transplantation.
Asunto(s)
Cardiomiopatías/etiología , Enfermedad Hepática en Estado Terminal/etiología , Sobrecarga de Hierro/etiología , Trasplante de Hígado , Adulto , Anciano , Cardiomiopatías/sangre , Estudios de Cohortes , Enfermedad Hepática en Estado Terminal/metabolismo , Enfermedad Hepática en Estado Terminal/cirugía , Femenino , Ferritinas/sangre , Genotipo , Supervivencia de Injerto , Proteína de la Hemocromatosis , Antígenos de Histocompatibilidad Clase I/genética , Humanos , Sobrecarga de Hierro/sangre , Masculino , Proteínas de la Membrana/genética , Persona de Mediana Edad , Mutación/genética , Complicaciones Posoperatorias , Estudios Retrospectivos , Factores de Riesgo , Tasa de Supervivencia , Adulto JovenRESUMEN
In the past 20 years, a variety of social media platforms have significantly changed how we interact, communicate, learn, and engage. Social media use by physicians and physicians in training has expanded dramatically and evolved in recent years. Here, we focus on the use of Twitter by medical professionals (#medtwitter) and analyze Twitter's role as a new tool for learning, teaching, networking, professional development, mentorship/sponsorship, and advocacy within medicine. We discuss principles of adult learning theory to support the effectiveness of the use of Twitter as an educational tool, and share best practice pearls as well.
Asunto(s)
Educación Médica , Difusión de la Información , Nefrología , Médicos , Comunicación Académica , Medios de Comunicación Sociales , Conflicto de Intereses , Defensa del Consumidor , Presentación de Datos , Humanos , Factor de Impacto de la Revista , Mentores , Revisión de la Investigación por ParesAsunto(s)
Neoplasias Cardíacas/secundario , Melanoma/secundario , Neoplasias Pancreáticas/secundario , Resultado Fatal , Femenino , Neoplasias Cardíacas/diagnóstico por imagen , Humanos , Melanoma/diagnóstico por imagen , Persona de Mediana Edad , Neoplasias Pancreáticas/diagnóstico por imagen , Tomografía Computarizada por Rayos XRESUMEN
BACKGROUND: Cervical spondylotic myelopathy often affects elderly and fragile patients who are not optimal candidates for major surgical procedures. Here, we report patients previously judged not suitable for cervical surgery, who were successfully treated with minimally invasive (MI) cervical decompressions without complications. METHODS: Retrospectively, we reviewed medically fragile patients (e.g., too many comorbidities), previously deemed unsuitable for surgery who successfully tolerated MI cervical decompressions. The accompanying preoperative comorbidities, surgical risks, complications, and neurological outcomes were assessed. RESULTS: Three male patients, with a mean age of 73 years, exhibited an average preoperative modified Japanese Orthopedic Association (mJOA) score of 8. The preoperative Charlson comorbidity indices, the Elixhauser comorbidity indices (respectively averaging 5.7 and 5.7 points, the preoperative Edmonton fragility index (average 12 points), and national surgical quality improvement program risks were calculated. Surgical times averaged 185 min and patients were followed for an average of 11.3 months. No patient had any immediate or delayed postoperative complications. The length of hospital stay was 1 day for each patient. The postoperative mJOA scores averaged 11, which was clinically significant. Further, the postoperative magnetic resonance imaging obtained approximately 3 months postoperative demonstrated adequate cord decompression. CONCLUSION: Medically fragile patients with significant cervical spondylotic myelopathy but major comorbidities precluding major surgery successfully underwent MI cervical decompressions.
RESUMEN
This cross-sectional study investigated the association of user sex and location with verification of physician-held social media accounts.